JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced ...
(RTTNews) - Quotient Ltd. (QTNT) reported that an independent study conducted in Madrid, Spain has confirmed the high performance characteristics of the company's MosaiQ COVID-19 Antibody Microarray.
Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback